CVIT2025app_e.png

mobileapps

General information

Announcements(1)

Session Map

Exhibition Map

CVIT2025 Website

Timetable

Thu. Jul 17, 2025

Fri. Jul 18, 2025

Sat. Jul 19, 2025

Program

Session List

Download Abstract in PDF

Search presentations

web_header_en.png

icon.png

Announcements

My schedule

My profile

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

Password is listed in "Guidelines for Attendees" section (p.34) on the CVIT2025 Pocket Program.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

The future outlook of heart failure/SHD treatments: How to evaluate patient&nbsp;reported outcomes

Heart Failure and Cardiogenic Shock: Data, Options and New Developments

In order for Japan's medical device industry to increase its international competitiveness and provide superior domestic technologies to the global market, it is essential that industry-government-academia collaboration, as well as institutional, funding, and evaluation systems, be in place. This session will bring together experts, entrepreneurs, government officials, industry associations, and policymakers from Japan and abroad to discuss the challenges and strategies for the global expansion of Japan's medical devices from multiple perspectives. From the perspectives of startup promotion, investment promotion, regulatory reform, and overseas expansion support, Diet members and key persons from relevant ministries and agencies will take the stage to introduce specific measures to accelerate medical device innovation. In addition, representatives from the PMDA, academia, and startups will discuss the current and future states of product evaluation, clinical needs, and regulatory responses. In the latter half of the panel discussion, we will share the results and future prospects of the Japan-U.S. collaborative program &ldquo;Harmonization By Doing (HBD)&rdquo; and examine the nature of the evaluation, including patient-reported outcomes (PRO) for heart failure and structural heart disease (SHD) treatment devices. Through this session, we will present a roadmap for Japan's medical devices to be accepted worldwide and discuss how to collaborate to achieve this goal.

Riding on the winds of World Expo 2025 in Osaka, we will bring new medical devices that were created with Japan's concentrated wisdom to the world [Interpretation En. &harr; Ja.]<pre class="sc-erUUZj kdBqQD">&nbsp;</pre>

第33回日本心血管インターベンション治療学会；CVIT2025学術集会

Presentation Information

[SP1-9]Heart Failure and Cardiogenic Shock: Data, Options and New DevelopmentsThe future outlook of heart failure/SHD treatments: How to evaluate patient reported outcomes

Password required to view